Compare GRFS & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | AVAV |
|---|---|---|
| Founded | 1940 | 1971 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 8.8B |
| IPO Year | 2008 | 2006 |
| Metric | GRFS | AVAV |
|---|---|---|
| Price | $7.32 | $160.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | $10.15 | ★ $316.88 |
| AVG Volume (30 Days) | 354.2K | ★ 2.1M |
| Earning Date | 07-28-2022 | 03-10-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.49 | $135.55 |
| Revenue Next Year | $6.42 | $14.90 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.96 | $135.20 |
| 52 Week High | $10.23 | $417.86 |
| Indicator | GRFS | AVAV |
|---|---|---|
| Relative Strength Index (RSI) | 35.57 | 54.42 |
| Support Level | $7.33 | $156.00 |
| Resistance Level | $8.41 | $162.30 |
| Average True Range (ATR) | 0.12 | 8.56 |
| MACD | -0.05 | 2.14 |
| Stochastic Oscillator | 5.76 | 75.55 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
AeroVironment Inc is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploys autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. The company operates business in two reportable segments: Autonomous Systems (AxS) and Space, Cyber and Directed Energy (SCDE). It derives majority of revenue from Autonomous Systems segment focuses on the design, development, production, delivery, and support of intelligent, multi-domain robotic systems, including UAS, uncrewed underwater vehicles and ground robot systems. Geographically it derives the majority of revenue from domestic operations.